177 related articles for article (PubMed ID: 10929025)
21. Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL-3), IL-6, granulocyte-macrophage colony stimulating factor (GM-CSF) and stem cell factor (SCF) in serum-supplemented and serum-free medium.
De Bruyn C; Delforge A; Bron D; Ley P; de Hemptinne D; Stryckmans P
Stem Cells; 1994 Nov; 12(6):616-25. PubMed ID: 7533580
[TBL] [Abstract][Full Text] [Related]
22. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
[TBL] [Abstract][Full Text] [Related]
23. Hematopoietic progenitor cell collection and neoplastic cell contamination in breast cancer patients receiving chemotherapy plus granulocyte-colony stimulating factor (G-CSF) or G-CSF alone for mobilization.
Bertolini F; Lanza A; Peccatori F; Zibera C; Gibelli N; Perotti C; Da Prada GA; Torretta L; Cocorocchio E; Martinelli G; Robustelli della Cuna G
Ann Oncol; 1998 Aug; 9(8):913-6. PubMed ID: 9789616
[TBL] [Abstract][Full Text] [Related]
24. Mobilization of blood-derived stem and progenitor cells in normal subjects by granulocyte-macrophage- and granulocyte-colony-stimulating factors.
Lane TA; Ho AD; Bashey A; Peterson S; Young D; Law P
Transfusion; 1999 Jan; 39(1):39-47. PubMed ID: 9920165
[TBL] [Abstract][Full Text] [Related]
25. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.
Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK
Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472
[TBL] [Abstract][Full Text] [Related]
26. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
McCrady CW; Li F; Pettit GR; Grant S
Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
[TBL] [Abstract][Full Text] [Related]
27. Combined use of growth factors to stimulate the proliferation of hematopoietic progenitor cells after autologous bone marrow transplantation for lymphoma patients.
Lemoli RM; Fortuna A; Fogli M; Rosti G; Gherlinzoni F; Visani G; Catani L; Gozzetti A; Tura S
Acta Haematol; 1996; 95(3-4):164-70. PubMed ID: 8677737
[TBL] [Abstract][Full Text] [Related]
28. Mobilization of peripheral blood stem cells with paclitaxel and rhG-CSF in high-risk breast cancer patients.
Meehan KR; Slack R; Gehan E; Herscowitz HB; Areman EM; Ebadi M; Cairo MS; Lippman ME
J Hematother Stem Cell Res; 2002 Apr; 11(2):415-21. PubMed ID: 11983113
[TBL] [Abstract][Full Text] [Related]
29. The "G-CSF test": the response to a single dose of granulocyte colony-stimulating factor predicts mobilization of hemopoietic progenitors in patients with hematologic malignancies.
Mijovic A; Pagliuca A; Mufti GJ
Exp Hematol; 1999 Jul; 27(7):1204-9. PubMed ID: 10390196
[TBL] [Abstract][Full Text] [Related]
30. [Mobilization of hematopoietic stem cells in peripheral blood by leukapheresis].
Zingsem J; Serke S; Zeiler T; Zimmermann R; Schwella N; Weisbach V; Eckstein R
Beitr Infusionsther; 1993; 31():111-7. PubMed ID: 7693238
[TBL] [Abstract][Full Text] [Related]
31. Primitive multilineage progenitor cells predominate in peripheral blood early after mobilization with high-dose cyclophosphamide and GM-CSF or G-CSF.
Croockewit S; Raymakers R; Trilsbeek C; Dolstra H; Pennings A; de Witte T
Leukemia; 1994 Dec; 8(12):2194-9. PubMed ID: 7528861
[TBL] [Abstract][Full Text] [Related]
32. Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell support.
Papadopoulos KP; Ayello J; Tugulea S; Heitjan DF; Williams C; Reiss RF; Vahdat LT; Suciu-Foca N; Antman KH; Hesdorffer CS
J Hematother; 1997 Feb; 6(1):61-8. PubMed ID: 9112219
[TBL] [Abstract][Full Text] [Related]
33. Potentiation of granulocyte colony-stimulating factor-induced mobilization of circulating progenitor cells by seven-day pretreatment with interleukin-3.
Geissler K; Peschel C; Niederwieser D; Strobl H; Goldschmitt J; Ohler L; Bettelheim P; Kahls P; Huber C; Lechner K; Höcker P; Kolbe K
Blood; 1996 Apr; 87(7):2732-9. PubMed ID: 8639889
[TBL] [Abstract][Full Text] [Related]
34. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
[TBL] [Abstract][Full Text] [Related]
35. Clinical application of in vitro expansion of cord blood.
Denning-Kendall PA; Horsley H; Nicol A; Nieda M; Bradley B; Hows JM
Bone Marrow Transplant; 1998 Jul; 22 Suppl 1():S63-5. PubMed ID: 9715893
[TBL] [Abstract][Full Text] [Related]
36. Effect of recombinant stem cell factor on clonogenic maturation and cycle status of human fetal hematopoietic progenitors.
Schibler KR; Ohls RK; Le T; Liechty KW; Christensen RD
Pediatr Res; 1994 Mar; 35(3):303-6. PubMed ID: 7514781
[TBL] [Abstract][Full Text] [Related]
37. Granulocyte colony-stimulating factor-mobilized peripheral blood CD34+ cells from children contain the same levels of long-term culture-initiating cells producing the same numbers of colony-forming cells as those from adults, but display greater in vitro monocyte/macrophage potential.
Boiret N; Kanold J; Bons JM; Rapatel C; Halle P; Tournilhac O; Guilhouard L; Guérin JJ; Travade P; Demeocq F; Bonhomme J; Berger MG
Br J Haematol; 2001 Mar; 112(3):806-13. PubMed ID: 11260087
[TBL] [Abstract][Full Text] [Related]
38. Kinetics of circulating haematopoietic progenitors during chemotherapy-induced mobilization with or without granulocyte colony-stimulating factor.
Liu KY; Akashi K; Harada M; Takamatsu Y; Niho Y
Br J Haematol; 1993 May; 84(1):31-8. PubMed ID: 7687859
[TBL] [Abstract][Full Text] [Related]
39. The expansion of megakaryocyte progenitors from CD34+-enriched mobilized peripheral blood stem cells is inhibited by Flt3-L.
Case J; Hicks C; Trickett A; Kwan YL; Manoharan A
J Interferon Cytokine Res; 2006 Feb; 26(2):76-82. PubMed ID: 16487027
[TBL] [Abstract][Full Text] [Related]
40. Application of whole blood and peripheral blood progenitor cells (PBPC) and new strategies for rescue after intensive cyclic chemotherapy in high-risk breast cancer.
Filip S; Bláha M; Odrázka K; Mericka P; Vávrová J
J Hematother Stem Cell Res; 2000 Feb; 9(1):31-8. PubMed ID: 10738969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]